Cytek Biosciences, Inc.
CTKB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6 | -$12 | $2 | $3 |
| Dep. & Amort. | $10 | $9 | $6 | $1 |
| Deferred Tax | -$3 | $0 | $0 | $0 |
| Stock-Based Comp. | $27 | $22 | $17 | $7 |
| Change in WC | $8 | -$11 | -$40 | -$9 |
| Other Non-Cash | -$11 | -$3 | $3 | $2 |
| Operating Cash Flow | $25 | $5 | -$12 | $5 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$5 | -$10 | -$4 |
| Net Acquisitions | -$0 | -$45 | $0 | -$17 |
| Inv. Purchases | -$274 | -$176 | -$46 | $0 |
| Inv. Sales/Matur. | $195 | $132 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | -$0 | $0 |
| Investing Cash Flow | -$83 | -$94 | -$56 | -$21 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $4 | -$1 | $3 | -$3 |
| Stock Issued | $0 | $0 | $0 | $216 |
| Stock Repurch. | -$22 | -$44 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $3 | $3 | $1 |
| Financing Cash Flow | -$16 | -$42 | $6 | $214 |
| Forex Effect | $5 | -$1 | -$2 | $1 |
| Net Chg. in Cash | -$69 | -$132 | -$65 | $198 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $168 | $300 | $365 | $166 |
| End Cash | $99 | $168 | $300 | $365 |
| Free Cash Flow | $22 | $0 | -$22 | $0 |